ARVN ARVINAS INC
2026Q1 · CUSIP 04335A105 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
206
Δ holders QoQ
+1
Breadth percentile
Top 58%
Whale holders
108
Δ whales
+1
Inst. holding value
$570M
New positions
35
Closed positions
34
Price momentum (1Q)
-23.3%
Put / Call
3/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 8 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q1 | Top 16% | +9.3% | +69.1% |
| 2023Q4 | Top 8% | -37.5% | -51.3% |
| 2023Q1 | Top 18% | +10.6% | -12.5% |
| 2021Q3 | Top 6% | -10.1% | -46.4% |
| 2020Q4 | Top 13% | -15.6% | +9.1% |
| 2019Q4 | Top 9% | -5.4% | -45.3% |
| 2019Q3 | Top 10% | +63.2% | +42.9% |
| 2019Q2 | Top 17% | +25.7% | +109.0% |
Options Sentiment
Put holders
3
QoQ: -1
Call holders
3
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-3.18
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)